Cytokinetics Inc (CYTK) — Strategic Asset Allocation Index
Cytokinetics Inc (CYTK) has a Strategic Asset Allocation Index of 281.3% as of June 2024. Strategic assets (PP&E of $- plus long-term investments of $305.36 Million) total $305.36 Million, measured against net assets of $108.55 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check CYTK asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Cytokinetics Inc Strategic Asset Allocation Index (2004–2021)
This chart shows how Cytokinetics Inc's Strategic Asset Allocation Index has evolved across 17 annual periods from 2004 to 2021. As of June 2024, the index stands at 281.3%, representing strategic assets of $305.36 Million against net assets of $108.55 Million USD. See financial agility of Cytokinetics Inc to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Cytokinetics Inc (2004–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Cytokinetics Inc from 2004 to 2021, covering 17 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Cytokinetics Inc market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 92.4% | $225.32 Million | $73.27 Million | $152.05 Million | $243.86 Million | ▲ +48.0 pp |
| 2020 | 44.4% | $50.30 Million | $13.35 Million | $36.95 Million | $113.38 Million | ▲ +32.0 pp |
| 2018 | 12.4% | $3.20 Million | $3.20 Million | $0.00 | $25.93 Million | ▼ -5.9 pp |
| 2017 | 18.3% | $20.09 Million | $3.57 Million | $16.52 Million | $109.84 Million | ▲ +6.3 pp |
| 2016 | 12.0% | $11.31 Million | $3.64 Million | $7.67 Million | $94.36 Million | ▲ +9.2 pp |
| 2015 | 2.8% | $1.93 Million | $1.75 Million | $179.00K | $68.59 Million | ▲ +1.0 pp |
| 2014 | 1.8% | $1.64 Million | $1.64 Million | $- | $92.06 Million | ▼ -5.1 pp |
| 2013 | 6.8% | $3.72 Million | $1.22 Million | $2.50 Million | $54.44 Million | ▲ +5.4 pp |
| 2012 | 1.4% | $997.00K | $997.00K | $- | $71.44 Million | ▼ -1.3 pp |
| 2011 | 2.7% | $1.31 Million | $1.31 Million | $- | $48.18 Million | ▼ -0.6 pp |
| 2010 | 3.3% | $2.32 Million | $2.32 Million | $- | $70.52 Million | ▼ -0.4 pp |
| 2009 | 3.7% | $3.71 Million | $3.71 Million | $- | $101.43 Million | ▼ -6.6 pp |
| 2008 | 10.2% | $5.09 Million | $5.09 Million | $- | $49.77 Million | ▲ +2.5 pp |
| 2007 | 7.7% | $7.73 Million | $7.73 Million | $- | $99.92 Million | ▼ -0.9 pp |
| 2006 | 8.7% | $9.20 Million | $9.20 Million | $- | $106.31 Million | ▲ +0.3 pp |
| 2005 | 8.4% | $6.18 Million | $6.18 Million | $- | $73.56 Million | ▲ +1.6 pp |
| 2004 | 6.8% | $7.34 Million | $7.34 Million | $- | $107.56 Million | — |